“Drugmakers have to take a hard look at calibrating those launch prices out of the gate … so they don’t box themselves in to a point where, in the future, they can’t claw their way back into profitability,” he said. .
More drug prices are likely to be announced during January – historically the biggest month for drug makers to raise prices.
To date, Pfizer announced the most increases, increasing prices on 89 unique drug brands, and additional increases on 10 drug brands in its Hospira arm.
GSK then has growth planned on 26 unique drugs so far, including an increase of about 7% on its popular shingles vaccine Shingrix.
GSK was not immediately available for comment.